Serum galactomannan surveillance may be safely withdrawn from antifungal management of hematology patients on effective antimold prophylaxis: a pilot single-center study

Editorial Commentary: Galactomannan Testing During Mold-Active Prophylaxis

(2014) O. A. Cornely   CLINICAL INFECTIOUS DISEASES

Serum Galactomannan Versus a Combination of Galactomannan and Polymerase Chain Reaction-Based Aspergillus DNA Detection for Early Therapy of Invasive Aspergillosis in High-Risk Hematological Patients: A Randomized Controlled Trial

(2014) J. M. Aguado et al.   CLINICAL INFECTIOUS DISEASES

Serum Galactomannan-Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis

(2014) R. F. Duarte et al.   CLINICAL INFECTIOUS DISEASES

Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation

(2010) I Sánchez-Ortega et al.   BONE MARROW TRANSPLANTATION

Galactomannan Detection and Diagnosis of Invasive Aspergillosis

(2010) J. Peter Donnelly et al.   CLINICAL INFECTIOUS DISEASES

Empirical versus Preemptive Antifungal Therapy for High‐Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial

(2009) Catherine Cordonnier et al.   CLINICAL INFECTIOUS DISEASES

Clinically Driven Diagnostic Antifungal Approach in Neutropenic Patients: A Prospective Feasibility Study

(2009) Corrado Girmenia et al.   JOURNAL OF CLINICAL ONCOLOGY

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES